论文部分内容阅读
目的探讨血清超敏C反应蛋白(hs-CRP)在糖尿病早期肾损伤诊断中的应用价值。方法对58例早期糖尿病肾病(DN)患者和55例正常对照者的血清hs-CRP进行测定分析。结果早期DN患者的hs-CRP含量为(15.87±8.38)mg/L,正常对照者的hs-CRP含量为(3.92±2.81)mg/L,经统计学处理,早期DN组的血清hs-CRP含量显著高于正常对照组(P<0.01)。结论hs-CRP是诊断糖尿病早期肾损伤的有价值的实验室指标。
Objective To investigate the value of serum hs-CRP in the diagnosis of early diabetic nephropathy. Methods Serum hs-CRP level in 58 patients with early diabetic nephropathy (DN) and 55 normal controls were measured. Results The hs-CRP level in early DN patients was (15.87 ± 8.38) mg / L, and that in normal controls was (3.92 ± 2.81) mg / L. The serum hs-CRP Content was significantly higher than the normal control group (P <0.01). Conclusion hs-CRP is a valuable laboratory index for the diagnosis of diabetic nephropathy.